Some possible healthcare-related risks of obesity include: Type 2 diabetes Heart disease and heart attacks Arthritis Gallbladder and fatty liver disease High cholesterol and high blood pressure Circulation problems and increase risks for stroke Infertility Osteoarthritis, in particular, the knees Sleep apnea and other breathing problems Certain kinds of cancer endometrial, breast, and colon Strain on bones, joints, and muscles due to increased weight Mobility issues Metabolic syndrome Emotional issues kidney disease and many others Semaglutide May Also Decrease Cardiometabolic Risks in Obese Patients Some medical experts predict that if obesity cases continue to rise, research has shown over the past three decades in the U.S., up to 50% of the population may be diagnosed with obesity by the year 2030
2025 ASCO Annual Meeting
Glutathione peroxidase 1 protects against peroxynitrite-induced spiral ganglion neuron damage through attenuating NF-B pathway activation
The results of combination treatments i.e
Because the drug levels in your body remain relatively stable over several days, minor shifts in your injection schedule, within the 48-hour window, do not significantly impact the overall concentration of the medication
It is banned at all times for athletes under WADA oversight